AMR seminar series: AMR surveillance and the ‘antibiotic footprint’

Thursday 25 November 2021
11:00am - 12:00pm
Online event
Lectures and seminars
General public

Join us for the first talk of the AMR@Leeds seminar programme 2021-22.

What is the seminar about?

How to support the generation and sharing of AMR surveillance reports, and how to solve the problem of low blood culture utilization in low and middle-income countries.


Dr Direk Limmathurotsakul, Mahidol-Oxford Tropical Medicine Research Unit 

Direk is the Head of Microbiology at Mahidol-Oxford Tropical Medicine Research Unit and Associate Professor at Faculty of Tropical Medicine, Mahidol University, Thailand. Antimicrobial resistance (AMR) is one of Direk's main research areas.

Direk estimated that 19,122 in Thailand in 2010 represented excess mortality caused by AMR (eLIFE 2016). Together with Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC), Direk showed that the global burdens of AMR estimated in previous studies are not comparable because of their different methodological approaches, assumptions, and data used to generate the estimates (LID 2019). 

Direk advocates the concept of ‘antibiotic footprint’ as a tool to communicate to the public the magnitude of antibiotic use in humans, animals and industry. Antibiotic footprint could be estimated by combining the total amount of antibiotics consumed by humans and animals in the country (JAC 2019).

His team also developed AMASS, an offline, open-access and easy-to-use application that allows a hospital to perform data analysis and generate AMR surveillance reports automatically and independently (JMIR 2020). 

To support communication with lay people and solve a problem of jargon surrounding AMR in local languages, Direk also initiated the AMR Dictionary (Wellcome Open Res 2021).


The seminar will take place on Zoom.